ID: ALA59861

Max Phase: Preclinical

Molecular Formula: C18H26N2O2S

Molecular Weight: 334.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNC(=O)[C@H](Cc1ccccc1)NC(=O)C1(CS)CCCCC1

Standard InChI:  InChI=1S/C18H26N2O2S/c1-19-16(21)15(12-14-8-4-2-5-9-14)20-17(22)18(13-23)10-6-3-7-11-18/h2,4-5,8-9,15,23H,3,6-7,10-13H2,1H3,(H,19,21)(H,20,22)/t15-/m0/s1

Standard InChI Key:  OPPRSMACRJLYDL-HNNXBMFYSA-N

Associated Targets(Human)

MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Timp3 Tissue inhibitor of metalloproteinases-3 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.49Molecular Weight (Monoisotopic): 334.1715AlogP: 2.34#Rotatable Bonds: 6
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.06CX Basic pKa: CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.20

References

1. Fink CA, Carlson JE, Boehm C, McTaggart P, Qiao Y, Doughty J, Ganu V, Melton R, Goldberg R..  (1999)  Design and synthesis of thiol containing inhibitors of matrix metalloproteinases.,  (2): [PMID:10021927] [10.1016/s0960-894x(98)00716-1]

Source